Perbandingan Kadar Serum Tnf Α (Tumor Necrosis Factor Α) Dengan Cytotoxin - Associated Gene A (Caga) Positif Dan Negatif Pada Penderita Gastritis Helicobacter Pylori
DAFTAR PUSTAKA
1.
Miernyk K, Morris J, Bruden D, et al. Charcterization of Helicobacter pylori
cagA
and vacA Genotypes among Alaskans and their correlation with
Clinical Disease. Journal of clinical microbiology. Sept. 2011, p. 3114-3121
2.
Zabaglia LM, Ferraz MA, et al. Lack of association among TNF-α gene
expression, -308 polymorphism (G>A) and virulence markers of Helicobacter
pylori. Journal of Venomous Animals and Toxins including Tropical disease.
2015;21;54.
3.
Yea SS, Yang YI, et al. Association between TNF-α promoter polymorphism
and Helicobacter pylori cagA subtype infection. J Clin Pathol. 2001; 54:703706.
4.
Zalewska-Z, Joanna K, Jarzab B, Krawkoczyk L. TNF – α expression in
gastric mucosa of individuals infected with different virulent Helicobacter
pylori strains. J Med Sci Monit 2009;15 (6): BR166-171.
5.
Rudi J, Kolb C, et al. Diversity of Helicobacter pylori VacA and CagA genes
and Relationship to VacA and CagA protein expression, Cytotoxin
Production, and Associated Disease. Journal of Clinical Microbiology. Apr.
1988, p. 944-948.
6.
Bauer B, Meyer TF. Review article: The Human Gastric Pathogen
Helicobacter pylori and its association with gastric cancer and ulcer disease.
Hindawi Publising Corporation. 2011.
7. Guerero S, Varela E, Gutierrez G, Vidal Y, Rojas G, et al. The Role of CagA
Protein Signaling in Gastric Carcinogenesis — CagA Signaling in Gastric
Carcinogenesis. INTECH Gastroenterology “Current Topics in Gastritis”.
Chapter 11. 2013;126:37-42.
8. Mahdi B. Immune Response to Helicobacter pylori, editor. Trends in
Helicobacter pylori Infection. Croatia: InTech Publishers; 2014. Chapter 2.
9. Alamsyah G, Rivalino R. Hubungan Tnf-Αlpha Dengan Derajat Keparahan
Gastritis Secara Histopatologi. Repositori USU. 2014.
44
Universitas Sumatera Utara
10. Rani A, Simadibrata M, Fahrial A, Buku Ajar Gastroenterologi Edisi Kesatu,
Internal Publising: 2011; 356-363.
11. Hirlan, Gastritis dalam Buku Ajar Ilmu Penyakit Dalam Edisi 5, Internal
Publishing : 2009 ; 509-512
12. Elseweidy MM. Helicobacter pylori infection and its relevant to chronic
gastritis. INTECH.2013.
13. Baratawidjaja KG. Imunologi Dasar: Sitokin. Jakarta: Balai Penerbit FK-UI;
2004; 128-31
14. Cavalcante M, Silva C, Neto M, Fialho A, Barbosa A, Cruz F, Rocha G, et al.
Helicobacter pylori vacA and cagA genotypes in patients from notheastern
Brazil with upper gastrointestinal disease. Mem Inst Oswaldo Cruz, Rio de
Janeiro, Vol. 107 (4) June 2012:561-563.
15. Doorn L, Schneeberger P, Nouhan N, Plaisier A, Quint W, Boer W.
Importance of helicobacter pylori CagA and vacA status for the efficacy of
antibiotic treatment. Gut.Bmj, 2000;46:321-326.
16. Goto, H. Helicobacter pylori and gastric disease. Nagoya J. Med Sci. , 2003;
77-85.
17. Bodger K, Crabtree J. Helicobacter pylori and gastric inflammation. British
Medical bulletin 1988;54 (No.1): 139-150.
18. Yamamoto T, Kita M, Ohno T, Iwakura Y, Sekikawa K, Imanishi J. Role of
Tumor Necrosis Factor – Alpha and Interferon-Gamma in Helicobacter pylori
Infection. Microbiol.Immunol., 2004, 647-654,.
19. Supajatura V, Ushio H, Wada A, Yahiro K, Okumura K, Ogawa H, et al.
Cutting Edge: VacA, a Vacuolating Cytotoxin of Helicobacter pylori,
Directly
Activates
Mast
Cells
for
Migration
and
Production
of
Proinflammatory Cytokines. J Immunol 2002; 168: 2603-2607.
20. Tanigawa T, Watanabe T, Higuchi K, Machida H, Okazaki H, Yamagami H,
Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, et al: Lansoprazole, a
Proton Pump Inhibitor, Suppresses Production of Tumor Necrosis Factor
alpha and Interleukin-1beta Induced by Lipopolysaccharide and Helicobacter
Pylori Bacterial Components in Human Monocytic Cells via Inhibition of
45
Universitas Sumatera Utara
Activation of Nuclear Factor-kappaB and Extracellular Signal-Regulated
Kinase. J Clin Biochem Nutr. 2009, 45(1):86–92.
21. Israel DA, Peek RM. Review article: Pathogenesis of Helicobacter pyloriinduced gastric inflammation. Aliment Pharmacol Ther. 2001;15:1271-90.
22. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. British
Med Bull. 1998;54:139-50
23. Holck S, Norgaard A, Bennedsen M, Permin H, Norn S, Andersen LP, et al.
Gastric mucosal cytokine responses in Helicobacter pylori-infected patients
with gastritis and peptic ulcers. Association with inflammatory parameters
and bacteria load. FEMS Immunology and Medical Microbiology.
2003;36:175-80.
24. Detrick, B., C. Nagineni, and J. Hooks, Cytokines: Regulators of Immune
Responses and Key Therapeutic Targets In: MRGOGaAD Donnenberg.
Human Immunology, CRC Press, Taylor & Francis Group, 2008: p. 495-516
25. Bradley JR. TNF-mediated inflammatory disease. J Pathol. 2008; 214:149-60.
26. Sastroasmoro, S. Dasar-dasar Metodologi Penelitian Klinis. Ed ke-3. Sagung
Seto,2007.
28. Zhu Y, Zhong X, Du Zheng SO, Xu W: Transformated immortalized gastric
epithelial cells by virulence factor CagA of Helicobacter pylori through Erk
mitogen-activated protein kinase pathway. Oncogene, 2005; 24: 3886–95
29. González-Valencia G, Atherton JC, Muñoz O et al: Helicobacter pylori vacA
and cagA genotypes in Mexican adults and children. J Infect Dis, 2000; 182:
1450–54
30. Qiao W, Hu J-L, Xiao B et al: CagA and vacA genotype of Helicobacter
pylori associated with gastric diseases in Xi’an area. World J Gastroenterol,
2003; 9: 1762–66
31. Gzyl A, Augustynowicz E, Dzierżanowska D et al: Genotypes of Helicobacter
pylori in Polish Population. Acta Microbiol Pol, 1999; 48: 261–75
32. Dzierżanowska D, Murawska B, Patzer J, Gzyl A: Application of molecular
techniques for diagnosis of Helicobacter pylori infections. Mikrobiol Med,
1998; 2: 48–52
46
Universitas Sumatera Utara
33. van Doorn, L-J, Figueiredo C, Sanna R et al: Clinical relevance of the cagA,
vacA, and iceA status of Helicobacter pylori. Gastroenterol, 1998; 115: 58–66
34. van Doorn L-J, Figueiredo C, Mégraud F et al: Geographic distribution of
vacA allelic types of Helicobacter pylori. Gastroenterol, 1999; 116: 823–30
35. Ando T, Peek RM, Pride D et al: Polymorphisms of Helicobacter pylori
HP0638 refl ect geographic origin and correlate with cagA status. J Clin
Microbiol, 2002; 40: 239–46
36. Lehmann FS, Terracciano L, Carena I et al: In situ correlation of cytokine
secretion and apoptosis in Helicobacter pylori-associated gastritis. Am J
Physiol Gastrointest Liver Physiol, 2002; 283: G481–88
37. Suganuma M, Kuzuhara T, Yamaguchi K, Fujiki H: Carcinogenic role of
tumor necrosis factor-a inducing protein of Helicobacter pylori in human
stomach. J Biochem Mol Biol, 2006; 39: 1–8
38. Woolf N: Cell, tissue and disease. The basis of pathology. 3rd ed. London,
England: WB Saunders Company Ltd., 2000
39. Yamaoka Y, Kita M, Kodama T et al: Induction of various cytokines and
development of severe mucosal infl ammation by cagA gene positive
Helicobacter pylori strains. Gut, 1997; 41: 442–51
40. Rad R, Gerhard M, Lang R et al: The Helicobacter pylori blood
antigenbinding adhesin facilitates bacterial colonization and augments a
nonspecific immune response. J Immunol, 2002; 168: 3033–41
41. Allen RD: Polymorphism of the human TNF-alpha promoter – random
variation or functional diversity? Mol Immunol, 1999; 36: 1017–27
42. Rad R, Dossumbekova A, Neu B et al: Cytokine gene polymorphisms
influence mucosal cytokine expression, gastric infl ammation, and host
specific colonisation during Helicobacter pylori infection. Gut, 2004;
53:1082–89
43. Kim N, Cho S-I, Yim J-Y et al: The effects of genetic polymorphisms of IL-1
and TNF-A on Helicobacter pylori-induced gastroduodenal diseases in Korea.
Helicobacter, 2006; 11: 105–12
47
Universitas Sumatera Utara
44. Hatekeyama M, Brzozowski T: Pathogenesis of Helicobacter pylori infection.
Helicobacter, 2006; 11(Suppl.1); 14–20
45. Reider G, Merchant JL, Haas R: Helicobacter pylori cag-type IV secretion
system facilitates 17 corpus colonization to induce precancerous conditions in
Mongolian gerbils. Gastroenterol, 2005; 128: 1229–42
46. Yokoyama K, Higashi H, Ishikawa S et al: Functional antagonism between
Helicobacter pylori CagA and vacuolating toxin VacA in control of the NFAT
signaling pathway in gastric epithelial cells. Proc Natl Acad Sci USA, 2005;
102: 9661–66
48
Universitas Sumatera Utara
1.
Miernyk K, Morris J, Bruden D, et al. Charcterization of Helicobacter pylori
cagA
and vacA Genotypes among Alaskans and their correlation with
Clinical Disease. Journal of clinical microbiology. Sept. 2011, p. 3114-3121
2.
Zabaglia LM, Ferraz MA, et al. Lack of association among TNF-α gene
expression, -308 polymorphism (G>A) and virulence markers of Helicobacter
pylori. Journal of Venomous Animals and Toxins including Tropical disease.
2015;21;54.
3.
Yea SS, Yang YI, et al. Association between TNF-α promoter polymorphism
and Helicobacter pylori cagA subtype infection. J Clin Pathol. 2001; 54:703706.
4.
Zalewska-Z, Joanna K, Jarzab B, Krawkoczyk L. TNF – α expression in
gastric mucosa of individuals infected with different virulent Helicobacter
pylori strains. J Med Sci Monit 2009;15 (6): BR166-171.
5.
Rudi J, Kolb C, et al. Diversity of Helicobacter pylori VacA and CagA genes
and Relationship to VacA and CagA protein expression, Cytotoxin
Production, and Associated Disease. Journal of Clinical Microbiology. Apr.
1988, p. 944-948.
6.
Bauer B, Meyer TF. Review article: The Human Gastric Pathogen
Helicobacter pylori and its association with gastric cancer and ulcer disease.
Hindawi Publising Corporation. 2011.
7. Guerero S, Varela E, Gutierrez G, Vidal Y, Rojas G, et al. The Role of CagA
Protein Signaling in Gastric Carcinogenesis — CagA Signaling in Gastric
Carcinogenesis. INTECH Gastroenterology “Current Topics in Gastritis”.
Chapter 11. 2013;126:37-42.
8. Mahdi B. Immune Response to Helicobacter pylori, editor. Trends in
Helicobacter pylori Infection. Croatia: InTech Publishers; 2014. Chapter 2.
9. Alamsyah G, Rivalino R. Hubungan Tnf-Αlpha Dengan Derajat Keparahan
Gastritis Secara Histopatologi. Repositori USU. 2014.
44
Universitas Sumatera Utara
10. Rani A, Simadibrata M, Fahrial A, Buku Ajar Gastroenterologi Edisi Kesatu,
Internal Publising: 2011; 356-363.
11. Hirlan, Gastritis dalam Buku Ajar Ilmu Penyakit Dalam Edisi 5, Internal
Publishing : 2009 ; 509-512
12. Elseweidy MM. Helicobacter pylori infection and its relevant to chronic
gastritis. INTECH.2013.
13. Baratawidjaja KG. Imunologi Dasar: Sitokin. Jakarta: Balai Penerbit FK-UI;
2004; 128-31
14. Cavalcante M, Silva C, Neto M, Fialho A, Barbosa A, Cruz F, Rocha G, et al.
Helicobacter pylori vacA and cagA genotypes in patients from notheastern
Brazil with upper gastrointestinal disease. Mem Inst Oswaldo Cruz, Rio de
Janeiro, Vol. 107 (4) June 2012:561-563.
15. Doorn L, Schneeberger P, Nouhan N, Plaisier A, Quint W, Boer W.
Importance of helicobacter pylori CagA and vacA status for the efficacy of
antibiotic treatment. Gut.Bmj, 2000;46:321-326.
16. Goto, H. Helicobacter pylori and gastric disease. Nagoya J. Med Sci. , 2003;
77-85.
17. Bodger K, Crabtree J. Helicobacter pylori and gastric inflammation. British
Medical bulletin 1988;54 (No.1): 139-150.
18. Yamamoto T, Kita M, Ohno T, Iwakura Y, Sekikawa K, Imanishi J. Role of
Tumor Necrosis Factor – Alpha and Interferon-Gamma in Helicobacter pylori
Infection. Microbiol.Immunol., 2004, 647-654,.
19. Supajatura V, Ushio H, Wada A, Yahiro K, Okumura K, Ogawa H, et al.
Cutting Edge: VacA, a Vacuolating Cytotoxin of Helicobacter pylori,
Directly
Activates
Mast
Cells
for
Migration
and
Production
of
Proinflammatory Cytokines. J Immunol 2002; 168: 2603-2607.
20. Tanigawa T, Watanabe T, Higuchi K, Machida H, Okazaki H, Yamagami H,
Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, et al: Lansoprazole, a
Proton Pump Inhibitor, Suppresses Production of Tumor Necrosis Factor
alpha and Interleukin-1beta Induced by Lipopolysaccharide and Helicobacter
Pylori Bacterial Components in Human Monocytic Cells via Inhibition of
45
Universitas Sumatera Utara
Activation of Nuclear Factor-kappaB and Extracellular Signal-Regulated
Kinase. J Clin Biochem Nutr. 2009, 45(1):86–92.
21. Israel DA, Peek RM. Review article: Pathogenesis of Helicobacter pyloriinduced gastric inflammation. Aliment Pharmacol Ther. 2001;15:1271-90.
22. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. British
Med Bull. 1998;54:139-50
23. Holck S, Norgaard A, Bennedsen M, Permin H, Norn S, Andersen LP, et al.
Gastric mucosal cytokine responses in Helicobacter pylori-infected patients
with gastritis and peptic ulcers. Association with inflammatory parameters
and bacteria load. FEMS Immunology and Medical Microbiology.
2003;36:175-80.
24. Detrick, B., C. Nagineni, and J. Hooks, Cytokines: Regulators of Immune
Responses and Key Therapeutic Targets In: MRGOGaAD Donnenberg.
Human Immunology, CRC Press, Taylor & Francis Group, 2008: p. 495-516
25. Bradley JR. TNF-mediated inflammatory disease. J Pathol. 2008; 214:149-60.
26. Sastroasmoro, S. Dasar-dasar Metodologi Penelitian Klinis. Ed ke-3. Sagung
Seto,2007.
28. Zhu Y, Zhong X, Du Zheng SO, Xu W: Transformated immortalized gastric
epithelial cells by virulence factor CagA of Helicobacter pylori through Erk
mitogen-activated protein kinase pathway. Oncogene, 2005; 24: 3886–95
29. González-Valencia G, Atherton JC, Muñoz O et al: Helicobacter pylori vacA
and cagA genotypes in Mexican adults and children. J Infect Dis, 2000; 182:
1450–54
30. Qiao W, Hu J-L, Xiao B et al: CagA and vacA genotype of Helicobacter
pylori associated with gastric diseases in Xi’an area. World J Gastroenterol,
2003; 9: 1762–66
31. Gzyl A, Augustynowicz E, Dzierżanowska D et al: Genotypes of Helicobacter
pylori in Polish Population. Acta Microbiol Pol, 1999; 48: 261–75
32. Dzierżanowska D, Murawska B, Patzer J, Gzyl A: Application of molecular
techniques for diagnosis of Helicobacter pylori infections. Mikrobiol Med,
1998; 2: 48–52
46
Universitas Sumatera Utara
33. van Doorn, L-J, Figueiredo C, Sanna R et al: Clinical relevance of the cagA,
vacA, and iceA status of Helicobacter pylori. Gastroenterol, 1998; 115: 58–66
34. van Doorn L-J, Figueiredo C, Mégraud F et al: Geographic distribution of
vacA allelic types of Helicobacter pylori. Gastroenterol, 1999; 116: 823–30
35. Ando T, Peek RM, Pride D et al: Polymorphisms of Helicobacter pylori
HP0638 refl ect geographic origin and correlate with cagA status. J Clin
Microbiol, 2002; 40: 239–46
36. Lehmann FS, Terracciano L, Carena I et al: In situ correlation of cytokine
secretion and apoptosis in Helicobacter pylori-associated gastritis. Am J
Physiol Gastrointest Liver Physiol, 2002; 283: G481–88
37. Suganuma M, Kuzuhara T, Yamaguchi K, Fujiki H: Carcinogenic role of
tumor necrosis factor-a inducing protein of Helicobacter pylori in human
stomach. J Biochem Mol Biol, 2006; 39: 1–8
38. Woolf N: Cell, tissue and disease. The basis of pathology. 3rd ed. London,
England: WB Saunders Company Ltd., 2000
39. Yamaoka Y, Kita M, Kodama T et al: Induction of various cytokines and
development of severe mucosal infl ammation by cagA gene positive
Helicobacter pylori strains. Gut, 1997; 41: 442–51
40. Rad R, Gerhard M, Lang R et al: The Helicobacter pylori blood
antigenbinding adhesin facilitates bacterial colonization and augments a
nonspecific immune response. J Immunol, 2002; 168: 3033–41
41. Allen RD: Polymorphism of the human TNF-alpha promoter – random
variation or functional diversity? Mol Immunol, 1999; 36: 1017–27
42. Rad R, Dossumbekova A, Neu B et al: Cytokine gene polymorphisms
influence mucosal cytokine expression, gastric infl ammation, and host
specific colonisation during Helicobacter pylori infection. Gut, 2004;
53:1082–89
43. Kim N, Cho S-I, Yim J-Y et al: The effects of genetic polymorphisms of IL-1
and TNF-A on Helicobacter pylori-induced gastroduodenal diseases in Korea.
Helicobacter, 2006; 11: 105–12
47
Universitas Sumatera Utara
44. Hatekeyama M, Brzozowski T: Pathogenesis of Helicobacter pylori infection.
Helicobacter, 2006; 11(Suppl.1); 14–20
45. Reider G, Merchant JL, Haas R: Helicobacter pylori cag-type IV secretion
system facilitates 17 corpus colonization to induce precancerous conditions in
Mongolian gerbils. Gastroenterol, 2005; 128: 1229–42
46. Yokoyama K, Higashi H, Ishikawa S et al: Functional antagonism between
Helicobacter pylori CagA and vacuolating toxin VacA in control of the NFAT
signaling pathway in gastric epithelial cells. Proc Natl Acad Sci USA, 2005;
102: 9661–66
48
Universitas Sumatera Utara